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Gentamicin treatment induces simultaneous mesangial prolif-
eration and apoptosis in rats.
Background. Gentamicin (G)-induced acute renal failure is
characterized by an impairment of glomerular function without
apparent changes in glomerular structure. However, G stimu-
lates reactive oxygen species (ROS)-mediated mesangial cell
proliferation in vitro. We studied whether G promotes mesan-
gial cell apoptosis in vitro, and if apoptosis and proliferation
in parallel may occur in glomerular cells in vivo after a renal
damage induced by G treatment.
Methods. For in vivo studies, rats were treated with G (100 mg/
kg body weight/day) for 6 days, and functional and histologic
studies were performed. For in vitro studies, mesangial cell
proliferation and apoptosis were evaluated after 24, 48, and
72 hours of 10−5 mol/L G incubation.
Results. After G injections, the number of nuclei per glomeru-
lus did not change, whereas proliferating and apoptotic cell
numbers increased. G increases DNA synthesis and cell num-
ber in cultured mesangial cells, and increases markedly the
apoptotic cell number. ROS scavengers superoxide dismu-
tase and catalase reduce G-induced mesangial cell apoptosis,
whereas the incubation with the ROS donor system xanthine
plus xanthine oxidase increases apoptosis to levels similar to G.
G-induced cellular proliferation and apoptosis either in vitro
or in vivo is associated to an early increase in the pro-apoptotic
protein Bax and a delayed increase in the survival protein Bcl-2.
Conclusion. G simultaneously induces proliferation and
apoptosis of mesangial cells in vitro and glomerular mesangial
cells in vivo. ROS may mediate G-induced mesangial apoptosis
in vitro. The equilibrium proliferation/apoptosis may maintain
mesangial cell number within normal limits after a G-induced
glomerular insult.
The main side effect of gentamicin (G) with clinical
relevance is nephrotoxicity. The major effect of G in
the kidney is tubular cell toxicity, but prolonged treat-
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ments also modify glomerular hemodynamics [i.e., re-
duces renal blood flow (RBF) and glomerular filtration
rate (GFR) without apparent glomerular damage] [1].
G-induced GFR reduction is attributed to a decline ei-
ther in glomerular plasma flow, ultrafiltration coefficient
(Kf), or both [2–4]. Kf regulation depends mainly on in-
traglomerular mesangial cells’ activity because they pos-
sess the capacity to contract or relax, thus modifying
the ultrafiltration surface, a dynamic phenomenon that is
highly regulated by numerous vasoactive substances [5].
Kf reduction observed after G treatment is attributed to
mesangial contraction [3, 4]. We reported that G induces
dose-dependent mesangial cell contraction and prolifer-
ation in vitro [6–8]. Nevertheless, despite the fact that G
activates cell proliferation, mesangial expansion is not a
characteristic of G-induced renal damage either in clini-
cal or experimental studies. We hypothesize that G might
also induce apoptosis, returning mesangial cell number to
control levels. Apoptosis is involved in cell deletion ob-
served in various glomerular diseases leading to sclero-
sis [9, 10]; mesangial proliferation followed by apoptosis
also occurs in anti-Thy1-induced proliferative glomeru-
lonephritis [11, 12]. Thus, the purpose of this study was
to assess if G-induced mesangial cell proliferation in
vitro is accompanied by apoptosis. Moreover, we assessed
whether G treatment in vivo simultaneously induces pro-
liferation and apoptosis in glomerular cells. In agreement
with our hypothesis, apoptosis has been recently observed
in two renal cell lines and in proximal tubular cells after
G treatment either in vitro or in vivo, respectively [13,
14].
Previous in vivo and in vitro studies strongly suggest the
mediation of ROS in the renal effects of G. Administra-
tion of antioxidants such as superoxide dismutase (SOD)
or dimethyl-thiourea prevented the G-induced GFR re-
duction [15–17]. Treatment with SOD in G-treated rats is
associated to an increase in RBF, and, therefore, super-
oxide anion (O2−) must be responsible for renal vasocon-
striction induced by G [15]. ROS scavengers are beneficial
in arresting renal damage developed after an injection
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of endotoxin and G [16]. Moreover, ROS are mediators
responsible for proximal tubular necrosis and acute re-
nal failure caused by G [18], and of the increased renal
susceptibility to G observed in obstructive jaundice [19].
In summary, an enhanced production of ROS, mainly
O2−, has consistently been involved in the development
of G-induced acute renal failure. The sources of ROS en-
hanced by G are isolated renal cortical mitochondria [20].
Recently, we showed that G elicited O2− production in
cultured mesangial cells via nitric oxide synthase (NOS)
and NAD(P)H oxidase activations. This O2− mediate
the proliferative response to G [21]. It is also well es-
tablished that free radicals induce apoptosis. Oxidant-
initiated apoptosis is described in mesangial cells [22],
and this process is proposed as the mechanism responsi-
ble for the loss of such cells in glomerular diseases [23].
Thus, another purpose was to study the mediation of re-
active oxygen species (ROS) in the possible apoptotic
effect of G in vitro.
METHODS
Materials and reagents
Xanthine (X), xanthine oxidase (XO), catalase (CAT),
SOD, propidium iodide, phenylmethylsulfoyl fluoride
(PMSF), Nonidet-P40 (NP40), and sodium dodecyl sul-
fate (SDS) were purchased from Sigma Quı´mica (Madrid,
Spain). [3H]-methyl thymidine was from New England
Nuclear (Bad Homburg, Germany). Crystal violet was
obtained from Fluka (Buchs, Switzerland). Super Sensi-
tive Immunodetection System and levamisol were pur-
chased by Biogenex Laboratories (San Ramo´n, CA,
USA). Mouse antihuman proliferative cell nuclear anti-
gen (PCNA) was from Cormedica Corp. (Medac Di-
agnostika, Wedel, Germany). Rabbit antihuman Bcl-2,
rabbit antimouse Bax, and biotinylated streptavidin-
alkaline phosphatase conjugated antibody were from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Goat
antirabbit IgG (H+L) and goat antimouse horseradish
peroxidase (HRP)-conjugated antibodies were from Bio-
Rad (Madrid, Spain). Annexin V-FITC was purchased
from PharMingen, BD Biosciences (San Jose, CA, USA).
Enhanced chemiluminescence (ECL) Western blotting
system was obtained from Amersham (Buckinghamshire,
UK). Terminal transferase, biotin dUTP, proteinase
K, and RNAse A were from Boehringer Mannheim
(Barcelona, Spain). Culture medium RPMI 1640 was
from Gibco Labs (Barcelona, Spain). Fetal calf serum
(FCS) and trypsin solution were from Whittaker Labs
(Barcelona, Spain). The sterile plastic material used in
cell culture was obtained from Nunc (Roskilde, Den-
mark). G sulfate was a kind gift of Shering Plough SA
(Madrid, Spain). All other reagents were of analyti-
cal grade and obtained from Sigma Quı´mica, Probus
(Madrid, Spain), and Merck (Madrid, Spain).
In vivo studies
G-induced nephrotoxicity in rats. In vivo experiments
were carried out in Wistar rats (250 g) placed into
metabolic cages in a temperature (20◦C)-, light-, and
humidity-controlled animal house. Daily subcutaneous
injections of G sulfate in saline solution (100 mg/kg body
weight) were administered; studies were performed in
rats treated with G during 2, 4, and 6 days, and 2 days
after finishing the treatment with G during 6 days.
Animals were treated following the Recommendations
from the Declaration of Helsinki and the Guiding Prin-
ciples in the Care and Use of Animals stated in the inter-
national regulations and in the following European and
national institutions: Conseil de l’Europe (published in
the Official Daily N. L358/1–358/6, 18th December 1986),
Spanish Government (published in Boletı´n Oficial del Es-
tado N. 67, pp. 8509–8512, 18th March 1988, and Boletı´n
Oficial del Estado N. 256, pp. 31349–31362, 28th October
1990).
Functional studies
Urine free of food and feces was collected daily. Urine
samples were used to determine creatinine concentra-
tion, urinary flow (UF), and urinary protein (UP), sodium
(UNa), and potassium (UK) excretions. We also took
daily blood samples (0.15 mL) from the caudal vein to de-
termine plasma creatinine concentration (PCr). Plasma
and urine creatinine concentrations were determined by
a colorimetric method based on the Jaffe´ reaction. UP
was measured by refractometry (Refractometer, Ameri-
can Optical Co., Buffalo, NY, USA). UNa and UK were
measured by flame photometry.
Histologic and immunohistochemical techniques. Rats
were anesthetized with ketamine (Ketolar, 50 mg/kg body
weight, intramuscular); kidneys were perfused through
the abdominal aorta with cold isotonic saline. Pieces of
each kidney were fixed by immersion in 4% buffered for-
malin for 24 hours. After dehydration, pieces were em-
bedded in paraffin. Sections (3-lm thick) were mounted
on glass slides and stained with hematoxylin-eosin; ad-
ditional sections were processed for immunohistochem-
istry to detect PCNA as previously described [24]. Thirty
glomerular sections were examined for each rat, and the
number of positively stained nuclei per glomerulus was
determined.
In vitro studies
Glomerular isolation and mesangial cell culture.
Glomeruli were isolated by successive mechanical siev-
ing of kidneys from 150 g Wistar rats, primary cultures
of mesangial cells were obtained as previously described,
and the identity of the cells was confirmed by morpho-
logic and functional criteria [25]. A cellular quiescent
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Fig. 1. Effect of gentamicin (G, 10−5 mol/L) on [3H-methyl]thymidine
incorporation into DNA (A) and on crystal violet nuclear staining (B) in
cultured mesangial cells at different times. The effect of G is compared
with the effect in nonstimulated cells incubated in the presence of 0.5%
fetal calf serum (FCS). Positive controls are mesangial cells incubated
in the presence of 10% FCS. Data are mean ± SEM of 4 experiments
performed by triplicate. ∗Statistically significant difference (P < 0.01)
with respect to cells incubated in 0.5% FCS.
state was induced as described [21]. Then, cells were re-
activated as described [21] in the presence of G (10−5
mol/L), and X (0.2 mmol/L) plus XO (2 mU/mL); in some
plates, SOD (15 U/mL) plus CAT (80 U/mL) were added
just before G. We previously showed that G stimulates
mesangial proliferation, with 10−5 mol/L being the con-
centration that induces the maximum response without
cytotoxic effects [6, 8].
Assessment of mesangial cell proliferation. Cell pro-
liferation was measured by both [3H-methyl]thymidine
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Fig. 2. Effect of gentamicin (G, 10−5 mol/L) on DNA fragmentation
detected by propidium iodide nuclear staining in cultured mesangial
cells at different times (A) or incubated (48 hours) in the presence of
reactive oxygen species (ROS) scavengers (B). The effect of G is com-
pared with the effect in nonstimulated cells incubated in the presence
of 0.5% fetal calf serum (FCS). Negative controls are mesangial cells
incubated in the presence of 10% FCS. Data are mean ± SEM (ex-
pressed as % of stained nuclei respect to the total number of nuclei)
of 3 experiments, 8 areas of 30 cells counted in each one. ∗Statistically
significant difference (P < 0.01) with respect to cells incubated in 0.5%
FCS (A) or with respect to cells incubated with G (B). SOD+CAT: 15
U/mL superoxide dismutase + 80 U/mL catalase.
incorporation into DNA and counting the number of vi-
able cells using the crystal violet method [21]. For this
purpose, cells were subcultured by treatment with 0.05%
trypsin and 0.02% EDTA, and plated in 6 × 4 well
plates. Experiments were performed on cells approach-
ing confluence from the first passage in order to avoid cell
de-differentiation.
Techniques to assess apoptosis. DNA fragmentation
associated with apoptosis was detected by the termi-
nal desoxynucleotidyl transferase (TdT)-mediated dUTP
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Fig. 3. Effect of gentamicin (G, 10−5 mol/L) on DNA fragmentation
detected by the TUNEL method in cultured mesangial cells at different
times (A) or incubated (48 hours) in the presence of reactive oxygen
species (ROS) scavengers and ROS donors (B). The effect of G is com-
pared with the effect in nonstimulated cells incubated in the presence
of 0.5% fetal calf serum (FCS). Negative controls are mesangial cells
incubated in the presence of 10% FCS. Data are mean ± SEM (ex-
pressed as % of stained cells with respect to the total number of cells)
of 3 experiments, 8 areas of 30 cells counted in each one. ∗Statistically
significant difference (P < 0.01) with respect to cells incubated in 0.5%
FCS (A) or with respect to cells incubated with G (B). SOD+CAT: 15
U/mL superoxide dismutase + 80 U/mL catalase; X/XO: 0.2 mmol/L
xantine + 2 mU/mL xantine oxidase.
nick end-labeling (TUNEL) method and by nuclear stain-
ing with propidium iodide. For propidium-iodide staining,
renal slices (fixed as previously described for histologic
techniques) or monolayers of mesangial cells (fixed in 4%
buffered formalin) were incubated for 45 minutes at 37◦C
in phosphate-buffered saline (PBS) (pH 7.4) contain-
ing propidium iodide (0.1 lg/mL) plus RNAse A (1 lg/
mL). TUNEL labeling was performed as previously de-
scribed [10, 26]. Quantification of apoptotic nuclei in the
glomeruli of renal slices was performed as previously de-
scribed for the PCNA.
Previous papers have shown that the enzymatic meth-
ods of labeling DNA fragmentation associated with
apoptosis can also label necrotic cells with nonspecific
DNA degradation, and sometimes transient DNA strand
breaks that occurs in mitotic cells [27–29]. In the present
study, care was taken to exclude TUNEL-labeled nu-
clei that had the cellular appearance of mitosis or necro-
sis. When counting propidium-iodide labeled nuclei, only
those with obviously condensed chromatin were counted.
Early apoptosis was assessed using annexin
V-fluorescein isothiocyanate (FITC), which binds
to negatively charged phospholipid surfaces with a
higher specificity for phosphatidylserine than most other
phospholipids; translocation of phosphatidylserine to
the external cell surface occurs early in the apoptotic
process [30]. Annexin V-FITC binding was detected by
flow cytometry as previously described [30].
Western blot analysis. Immunoblots of mesan-
gial cells or glomeruli were carried out as previ-
ously described [31]. Proteins were separated in 15%
SDS-polyacrylamide gel. Primary antibodies (anti-Bcl-
2, anti-Bax, and anti-PCNA) and secondary antirabbit
IgG or antimouse HRP-conjugated antibodies were used
at final concentrations between 0.1 to 1 lg/mL and 0.01
to 1 lg/mL, respectively. For quantification, films were
digitalized with Adobe Photoshop 3.0, and relative opti-
cal densities for each lane were measured using an image
analysis program (MacBAS 2.2; Fuji Film, Rochester, NY,
USA).
Statistical methods
The Kolmogorov-Smirnov test was used to assess nor-
mality of the data distribution. One-way analysis of
variances (ANOVA) and Scheffe´’s test were used for
normally distributed data. Kruskal-Wallis multiple com-
parison Z-value test was used for non-Gaussian data.
A P value less than 0.05 was considered statistically
significant.
RESULTS
Effect of G on cultured mesangial cells apoptosis
and proliferation
The first purpose of our study was to assess the effect of
G on proliferation and apoptosis in mesangial cells. 10−5
mol/L G induced a significant increase in DNA synthe-
sis and viable cell number, with a maximal increase after
24-hour incubation and a further increase after 72-hour
incubation (Fig. 1). G also induced a marked increase
in the number of cells showing features of apoptosis as-
sessed by propidium iodide nuclear staining (Fig. 2A), by
TUNEL (Fig. 3A), and by flow cytometry using annexin
V-FITC (Fig. 4). Thus, these experiments demonstrate
that G simultaneously induces proliferation and apopto-
sis in mesangial cells.
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Fig. 4. Effect of gentamicin (G, 10−5 mol/L) on apoptosis detected by flow cytometry with annexin V-FITC in cultured mesangial cells at different
times. (A) The effect of G is compared with the effect in nonstimulated cells incubated in the presence of 0.5% fetal calf serum (FCS). Negative
controls are mesangial cells incubated in the presence of 10% FCS. Data are mean ± SEM (expressed as % of apoptotic cells with respect to the
total number of cells) of 4 experiments performed by triplicate. ∗Statistically significant difference (P < 0.01) with respect to cells incubated in
0.5% FCS. (B) Panels show a single experiment representative of the data shown in (A). Cell number (y axis) and fluorescence intensity of annexin
V-FITC (x axis, in logarithmic scale) is expressed in arbitrary units.
To assess if ROS production is involved in the prolif-
erative and apoptotic effect of G, we analyzed the effects
of ROS scavengers in mesangial cells. Incubation with
SOD (15 U/mL) + CAT (80 U/mL) significantly reduced
G-induced mesangial cell apoptosis assessed either by
propidium iodide nuclear staining (Fig. 2B) or by TUNEL
(Fig. 3B). The ROS donor system X (0.2 mmol/L) + XO
(2 mU/mL) induced an increase in the apoptotic rate sim-
ilar to that induced by G 10−5 mol/L (Fig. 3B).
The involvement of Bcl-2/Bax balance in G-induced
mesangial apoptosis was studied measuring the expres-
sion of both proteins in mesangial cells. The anti-
apoptotic protein Bcl-2 is expressed in cells cultured in a
serum-deprived medium (0.5% FCS); G induced a signif-
icant increase of Bcl-2 expression in quiescent cells only
after 72 hours of incubation (Fig. 5A). The proapoptotic
protein Bax is expressed in mesangial cells maintained in
0.5% FCS, and this expression increased after 24 hours
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Fig. 5. (A) Expression of the proteins Bcl-2 (upper panel) and Bax in
mesangial cells incubated with gentamicin (G, 10−5 mol/L) at different
times (lane 2: 24 h; lane 3: 48 h; lane 4: 72 h). The effect of G is compared
with the effect in nonstimulated cells incubated in the presence of 0.5%
fetal calf serum (FCS, lane 1). Positive controls are mesangial cells in-
cubated in the presence of 10% FCS (lane 5). Protein fractions (80 lg)
were size fractioned in a 15% polyacrylamide gel. The figure shows a
representative blot of 3 different immunoblots performed under sim-
ilar conditions. (B) Bars represent optical density (mean ± SEM) of
the bands from 3 different immunoblots, expressed as % of the band
obtained in nonstimulated cells incubated with of 0.5% fetal calf serum
(lane 1).
of incubation with G; Bax expression is minimal in cells
maintained in 10% FCS-containing medium (Fig. 5B).
Kidney alterations induced by G treatment in vivo
Treatment with G (100 mg/kg body weight/day) dur-
ing 6 days induced a polyuric acute renal failure as
demonstrated by the increased UF, UNa excretion, and
PCr, and by the decreased creatinine clearance (CrCl).
These changes persisted 2 days after the last administra-
tion of G (Table 1).
Light microscopy examination of renal tissue revealed
mild lesions after 4 days of G treatment; patchy cell necro-
sis appeared in more than 80% of the proximal tubules
in rats injected with G during 6 days (Fig. 6B). The tubu-
lar lumen was frequently filled with hyaline casts or het-
erogeneous cellular debris. The same pattern of lesions
was observed 2 days after finishing the treatment with
G. No apparent structural glomerular alterations were
observed.
Glomerular cell proliferation in vivo was assessed by
counting the number of glomerular PCNA-positive cells,
and by measuring the relative expression of PCNA in
glomerular lysates. PCNA-positive cell number increased
constantly along the study (Table 2). Cells expressing
PCNA seem to be mainly mesangial (Fig. 6D). Glomeru-
lar PCNA protein expression increased after 6 days of
G treatment and remained elevated 2 days after with-
drawal from the treatment (Fig. 7). The number of nu-
clei per glomerulus did not change with G treatment
(Table 2).
Glomerular apoptotic cell number was assessed with
two techniques, TUNEL and nuclear staining with pro-
pidium iodide (Fig. 8); apoptotic cell death increased af-
ter 2 days of G administration and remained constant 2
days after withdrawal of G injections (Fig. 9). Apoptosis
seemed to be mainly restricted to mesangial cells (Fig. 8).
The expression of Bcl-2 and Bax was checked by West-
ern blot in glomerular protein fractions. Bcl-2 was not
detectable in control rats. A later enhancement in Bcl-2
expression (up to 10 times) appeared in glomeruli after 6
days of G treatment (Fig. 10A). Bax expression increased
after 4 days of G treatment (Fig. 10B). The expression of
both Bcl-2 and Bax reached maximum values at the end
of the study (2 days after G withdrawal).
DISCUSSION
The aims of the present study were to elucidate whether
G promotes mesangial apoptosis (parallel with prolif-
eration) in vitro, and then correlate the effect of G in
vitro with its effect in vivo by studying cellular prolifer-
ation and apoptosis in glomeruli of rats subjected to an
acute systemic treatment with G up to 6 days. This study
emerged from the fact that a G insult modifies glomeru-
lar physiology by targeting the mesangium as part of the
cortical alterations that this antibiotic exerts on the kid-
ney [2–4]. Besides, it is widely demonstrated that G acti-
vates mesangial cell proliferation in vitro [21]. However,
nobody has reported an alteration of glomerular struc-
ture, including mesangial cell proliferation, in patients
or animals treated with G. Therefore, we hypothesized
that the effect of G on glomerular structure might be
characterized by mesangial cell proliferation followed by
cell apoptosis, thus maintaining glomerular cell number
within normal limits. The coincidence of both processes
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Table 1. Renal function studies in control rats and in rats treated with gentamicin (G, 100 mg/kg body weight/day) during 2, 4, 6 days, and 2 days
after finishing the treatment with G during 6 days (G 6+2 days)
UF PCr CrCl UP Una UK
lL/min mg/mL mL/min mg/day mEq/day mEq/day
Control (8 days) 3.54 ± 0.55 10.9 ± 1.6 0.56 ± 0.06 9.0 ± 2.3 0.20 ± 0.05 0.98 ± 0.15
G 2 days 2.73 ± 0.38 15.6 ± 1.5 0.39 ± 0.07 14.7 ± 1.5 0.14 ± 0.02 1.06 ± 0.14
G 4 days 4.36 ± 1.10 12.7 ± 0.8 0.35 ± 0.11 14.0 ± 3.0 0.29 ± 0.07 0.92 ± 0.24
G 6 days 8.77 ± 1.83a 18.5 ± 3.0a 0.27 ± 0.08a 30.6 ± 4.6a 0.53 ± 0.14a,b,c 1.39 ± 0.23
G 6+2 days 9.82 ± 1.76a 31.7 ± 3.3a,d 0.22 ± 0.05a 71.0 ± 10.8a,d 0.48 ± 0.10a,b 1.38 ± 0.19
Renal functional parameters measured were: urinary flow (UF), plasma creatinine (PCr), creatinine clearance (CrCl), proteinuria (UP), urinary sodium (UNa), and
urinary potassium (UK) excretions. Control rats received a similar volume of saline solution. Basal values of all functional parameters were obtained from each rat
before starting the treatment (N = 50, data not shown), and there were no differences with respect to control data after 8 days of saline solution injections. Data are
shown as mean ± SEM, N = 10 rats in each group. Statistical significant differences (P < 0.05) were: a vs. control; b vs. group treated with G 2 days; c vs. group treated
with G 4 days; d vs. groups treated with G 2, 4, and 6 days.
Table 2. Total number of cells and number of proliferating cells
(PCNA positive) per glomerular cross section in control rats and in
rats treated with gentamicin (G, 100 mg/kg body weight/day) during 2,
4, 6 days, and 2 days after finishing the treatment with G during 6 days
(G 6+2 days)
Number of proliferating cells Total number of cells
Control 0.58 ± 0.09 48.8 ± 6.2
G 2 days 1.57 ± 0.12a 59.4 ± 8.9
G 4 days 1.99 ± 0.22a 54.4 ± 7.9
G 6 days 2.19 ± 0.34a 54.6 ± 7.5
G 6+2 days 2.69 ± 0.56a 44.6 ± 6.8
Data are expressed as mean ± SEM of the number of nuclei counted in 50
glomerular cross-sections obtained per rat in 10 rats sacrificed at each of the
indicated times. aP < 0.001 vs. control.
was proposed as the mechanism involved in the glomeru-
lar cell loss observed in various glomerular diseases
[9–12].
Gentamicin induces ROS-mediated mesangial cell
apoptosis in vitro
An oxidative stress has been linked to the renal dys-
function caused by systemic treatment with G [15–20]. We
demonstrated that G and ROS, individually, can stimu-
late glomerular and mesangial cell contraction and pro-
liferation in vitro [6, 8, 32]. More recently we described
that mesangial cells exposed to G produced O2− through
NAD(P)H oxidase and NOS activation; this O2− medi-
ates the proliferative response to G [21]. Thus, we as-
sessed a possible apoptotic effect of G on glomerular
mesangial cells and the role of ROS as mediators of this
process.
The results of this study demonstrate that the maximal
noncytotoxic concentration of G (10−5 mol/L) induces an
increase in proliferation and apoptosis in mesangial cells.
An apoptotic effect of G in vitro was also recently recog-
nized in embryonic fibroblasts and in two renal epithelial
cell lines (LLC and MDCK cells) exposed during 4 days
to concentrations up to 3 × 10−6 mol/L [14] or for 15 days
to concentrations of 10−5 mol/L [33].
This study suggests that O2− are involved in G-induced
mesangial apoptosis because the O2− donor system X
plus XO enhanced the number of apoptotic cells in a
degree quantitatively similar to that induced by G. More-
over, G-induced apoptosis is inhibited by incubation with
SOD plus CAT, a ROS scavenger system. There is in-
creasing evidence showing that pro-oxidant stimuli elicit
an apoptotic response in mesangial cells [22, 23, 34–37].
In addition, glomerular and mesangial apoptosis induced
by tumor necrosis factor (TNF)-a and interleukin (IL)-1a
is mediated by ROS [36]. In agreement with our hypoth-
esis, O2− has been recognized as a selective mediator for
TNF-a-induced apoptosis of rat mesangial cells [38].
A balance between Bax and Bcl-2 proteins seems to
play a major role in the regulation of cellular apoptosis
and survival [39]. We observed that Bax is expressed in
mesangial cells maintained in a serum-deprived medium,
and that its expression increased early after G addition.
These results agree with the known proapoptotic role of
Bax. The mesangial content of Bcl-2, which is known to
block programmed cell death in quiescent mesangial cells,
was enhanced after 72 hours of incubation with G. There-
fore, G induced an oxidant-mediated apoptosis in mesan-
gial cells characterized by an early elevation in Bax and a
delayed increase in Bcl-2. An up-regulation of Bcl-2 ex-
pression has been also observed in an ovary cell line in
response to geneticin (G418), an aminoglycoside rather
similar to G [40]. Bcl-2 localizes at the sites of ROS gen-
eration, and is recognized to prevent oxidative damage.
Thus, a similar Bcl-2 overexpression was described to
have a protective role against oxidant-induced apopto-
sis in a neural cell line [41] and in mesangial cells [42].
In addition, Bcl-2 itself can function as an antioxidant to
prevent apoptosis [43, 44]. The delay in Bcl-2 increase in
G-stimulated mesangial cells is compatible with the hy-
pothesis, suggesting that it can be overexpressed in later
phases of the apoptotic process to protect cells against
further apoptosis [45].
Gentamicin induces glomerular cell proliferation
and apoptosis in vivo
The present study confirms that a daily injection of G
at the dose of 100 mg/kg body weight induced a polyuric
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Fig. 6. Light micrographs of sections from
kidneys stained with hematoxylin-eosin (A-
D) and immunhistochemistry for PCNA (E
and F). (A, C) Normal histology of kidney
tissue in control rats. (B) Massive tubular
necrosis with hyaline casts is observed in rats
treated with gentamicin (G, 100 mg/kg body
weight/day) during 6 days, and also several
mesangial cells apoptotic nuclei (D, arrows).
(E) Only occasional nuclei expressing PCNA
are observed in some tubules from control ani-
mals. (F) Numerous tubular and renal corpus-
cular cells are expressing the antibody in rats
treated during 6 days with G. Bar is 100 mi-
crons in A, B, and F; 50 microns in C and D,
and 200 microns in E.
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Fig. 7. (A) Expression of the protein PCNA in glomeruli of rats treated
with gentamicin (100 mg/kg body weight/day) (lane 2: 2 days; lane 3:
4 days; lane 4: 6 days; lane 5: 6 days plus 2 days maintained without
treatment). Protein fractions (80 lg) were size fractioned in a 15%
polyacrylamide gel. The figure shows a representative blot of 3 different
immunoblots performed under similar conditions. (B) Bars represent
optical density of the bands expressed as % of the band obtained in
untreated rats (lane 1).
acute renal failure evident after 6 days that persists,
and even aggravates, 2 days after. Our study also de-
scribes that G treatment in vivo induces a simultaneous
increase in glomerular cell proliferation and apoptosis
without changes in cell number. G apoptotic effect has
been widely described in ciliated cells of vestibular sen-
sory epithelium, where apoptosis seems to be the fate of
the majority of hair cells following a G insult [46]. The
few studies dealing with the apoptotic effect of G in the
kidney are restricted to the tubular epithelium, mainly
to proximal cells. Nouwen et al [27] demonstrated that
after G treatment, the strongly increased cell prolifera-
tion in regenerating necrotic proximal cells was preceded
by an equally important proliferation in the cortex dis-
tal tubules and outer stripe of the outer medulla, in the
absence of necrosis, but displaying enhanced apoptosis.
More recently, El-Moueden et al [13] showed apoptosis
in the proximal epithelium of rats treated with low ther-
apeutic doses of G (up to 20 mg/kg/day) during 10 days,
whereas other aminoglycosides, even at higher doses, ap-
peared safer in this respect. They also observed tubular
and peritubular cell proliferation. Therefore, this is the
first description of glomerular apoptosis induced by G in
vivo.
Glomerular apoptosis induced by other pharmacologic
agents in vivo remains to be studied. Cha et al [47] demon-
strated that mesangial cells exposed in vitro to cytotoxics
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Fig. 8. Representative images of renal corti-
cal slices of rats treated with gentamicin (100
mg/kg body weight/day during 6 days) after
nuclear staining with the TUNEL method (a
and b) or with propidium iodide (c and d).
In (b), nuclei with DNA fragmentation show
a more intensive coloration; in (d), apoptotic
cells were readily identifiable in an inverted
fluorescence microscope because they show
a striking nuclear staining with propidium io-
dide. Controls are shown in (a) and (c). Images
were color-enhanced using the Microsoft Pho-
toeditor, and in the case of TUNEL staining,
color was inverted to show a better contrast
and improve the nuclei counting.
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Fig. 9. DNA fragmentation detected by propidium iodide nuclear
staining (A) and by the TUNEL method (B) in glomeruli of rats treated
with gentamicin (100 mg/kg body weight/day) during 2, 4, and 6 days,
and 2 days after 6 days of treatment (6+2 days). Data are mean ± SEM
(expressed as % of stained nuclei with respect to the total number of
nuclei) of 200 glomeruli analyzed per group. Statistically significant dif-
ferences were ∗P < 0.01 and †P < 0.05 with respect to untreated control
rats.
or irradiation showed apoptosis identified by light mi-
croscopy; these authors suggest that cytotoxic drugs
used to treat glomerular disease can induce apoptotic
mesangial death in part via this mechanism. However,
they have studied the effect of these drugs only in
vitro.
Glomerular cell apoptosis appears to be associated
with a delayed increase in Bcl-2 expression in the last
days of treatment that tends to be higher after withdrawal
of G. Recent reports are in agreement with our observa-
tions because they show renal apoptosis associated with
increased Bcl-2 in ischemic acute renal failure [29]. Dur-
ing kidney tubular damage, DNA damage may manifest
itself as reparable single- and double-strand breaks [48,
49]. It can be hypothesized that cell protection via Bcl-2
up-regulation may allow time for DNA strand repair to
occur. The cells in which DNA repair is not completed
continue on to apoptosis.
Interestingly, we found that G induces glomerular
proliferation and apoptosis simultaneously. Proliferation
and apoptosis also coincide in tubular, interstitial, and
glomerular cells in a model of chronic obstructive uropa-
thy [50], and in a subtotal-nephrectomy model of chronic
renal failure correlating with the progression of renal fi-
brosis [51]. Glomerular proliferation and apoptosis have
been shown in several glomerulosclerotic lesions [9, 11,
12] and in glomeruli of uninephrectomized spontaneously
hypertensive rats [10].
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Fig. 10. (A) Expression of the proteins Bcl-2 (upper panel) and (B)
Bax (lower panel) in glomeruli of rats treated with gentamicin (100
mg/kg body weight/day) (lane 2: 2 days; lane 3: 4 days; lane 4: 6 days; lane
5: 6 days plus 2 days maintained without treatment). Protein fractions
(80 lg) were size fractioned in a 15% polyacrylamide gel. The figure
shows a representative blot of 3 different immunoblots performed un-
der similar conditions. (B) Bars represent optical density of the bands
expressed as % of the band obtained in untreated rats (lane 1).
CONCLUSION
This is the first observation of an apoptotic effect in-
duced by G in mesangial cells in vitro; this apoptosis
seems to be mediated by an elevation in ROS produc-
tion (at least, O2−). Simultaneously, G induces mesan-
gial cell proliferation. In addition, G treatment in vivo
also induces glomerular cell proliferation and apoptosis
(mainly in the mesangium). G-induced proliferation and
apoptosis either in vitro or in vivo are associated with
an early increase in the proapoptotic protein Bax and a
delayed increase in the survival-promoting protein Bcl-
2. We propose that the simultaneous occurrence of cel-
lular proliferation and apoptosis may be a mechanism
regulating glomerular cell number after acute treatment
with G.
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